Previous Article | Next Article ![]()
Infection and Immunity, January 2001, p. 589-592, Vol. 69, No. 1
Department of Microbiology and Immunology,
College of Veterinary Medicine, Cornell University, Ithaca, New
York,1 and Basel Institute for
Immunology, Basel, Switzerland2
Received 7 August 2000/Returned for modification 8 September
2000/Accepted 29 September 2000
An interleukin-4 (IL-4)-dependent Th2 response allows wild-type
mice to survive infection with the parasite Schistosoma
mansoni. In the absence of IL-4, infected mice mount a Th1-like
proinflammatory response, develop severe disease, and succumb. Neither
the Th1 response nor morbidity is IL-12 dependent in this system.
The immune response to
Schistosoma mansoni infection is characterized by elevated
production of type 2 cytokines, including interleukin-4 (IL-4), IL-5,
IL-10, and IL-13 (4, 9, 15). In the absence of IL-4,
spleen cells from schistosome-infected mice produce lower levels of
type 2 cytokines (IL-5, IL-10, and IL-13) and higher levels of
inflammatory mediators, including gamma interferon (IFN- The production of NO by cells such as macrophages and endothelial cells
is promoted by IFN- For these studies, we utilized C57BL/6 IL-4/IL-12p35
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.1.589-592.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Severe Schistosomiasis in the Absence of
Interleukin-4 (IL-4) Is IL-12 Independent


![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
), tumor
necrosis factor alpha (TNF-
), and nitric oxide (NO) (2, 5, 9,
15). Concurrent with this altered immune response, infected
IL-4
/
mice, unlike wild-type (WT) animals, develop
severe disease and die (2). The dramatic weight loss that
precedes death in this model suggests a role for inflammatory
mediators, such as TNF-
and associated molecules (IFN-
and NO),
in the disease (3, 6, 11, 20). Supporting this view that
severe disease is immunologically mediated, treatment with anti-TNF
monoclonal antibody, IL-4, anti-CD4 monoclonal antibody, or the
peroxynitrite scavenger uric acid was found to delay mortality
(2; A. C. La Flamme et al., submitted for
publication). Of the inflammatory mediators examined that could be
responsible for the exacerbated disease in infected
IL-4
/
mice, it is NO and its downstream product,
peroxynitrite, that are most tightly correlated with disease severity
(2; La Flamme et al., submitted).
. Since in many instances IL-12 is essential for
IFN-
production, we analyzed the role of IL-12 in the development of
severe schistosomiasis that occurs in the absence of IL-4, reasoning
that in the absence of IL-12, IFN-
and thus NO and peroxynitrite
production would be minimized. We hypothesized that this would result
in an alleviation of the disease and prolonged survival.
/
mice generated by Manfred Kopf by interbreeding IL-4
/
B6 mice (10) with IL-12p35
/
B6 mice
(12) to produce homozygous double knockouts. These mice
and the IL-4
/
and IL-12
/
mice were bred
at Cornell University. C57Bl/6 (WT) mice were purchased from Taconic
Farms, Germantown, N.Y. Mice were infected percutaneously with
approximately 70 S. mansoni cercariae (NMRI strain). From
day 35 of infection, mice were weighed using a spring balance (Forestry
Suppliers, Jackson, Miss.), and once one or more of the infected
IL-4
/
mice had lost ~20% of their body weight the
experiment was terminated (2). Differences in weight
changes in the infected mice were assessed using nonparametric
statistical analysis by the Wilcoxon signed rank test. We found that
the infected IL-4/IL-12
/
mice developed a severe
disease that was clinically indistinguishable from that seen in
infected IL-4
/
mice; this was defined by marked
cachexia followed by death (Fig. 1A and
B). Disease development in schistosome-infected IL-12
/
mice mirrored that in WT mice (Fig. 1).

View larger version (15K):
[in a new window]
FIG. 1.
Morbidity and mortality in infected WT,
IL-4
/
, IL-12
/
, and
IL-4/IL-12
/
mice. (A) Time course of cumulative weight
changes in infected animals following percutaneous exposure to ~70
cercariae. Changes in body weight are expressed as means ± standard errors of the means. There were five mice per group.
Cumulative weight changes in IL-4
/
and
IL-4/IL-12
/
mice were significantly different from
those in WT and IL-12
/
mice (*, P < 0.05). Results are representative of two separate experiments. (B)
Mortality over time in infected animals following percutaneous exposure
to ~90 cercariae. There were five mice per group. Mortality was
significantly higher in IL-4
/
and
IL-4/IL-12
/
mice than in WT and IL-12
/
mice (*, P < 0.05).
Since disease severity is related to infection intensity, we examined
whether the morbidity observed in infected IL-4/IL-12
/
mice was due to the survival of a greater percentage of the infectious inoculum in these mice than in IL-4
/
or WT mice. Mice
were infected with equal numbers of cercariae, and worms and eggs were
recovered and quantitated as previously described (2, 19).
Analysis of variance (ANOVA) was used to evaluate differences in worm
and egg burdens. We found no significant differences in either worm
burden (ANOVA, P = 0.67) or hepatic egg load (ANOVA,
P = 0.83) among the different groups (Table
1) and therefore conclude that the severe
morbidity observed in mice lacking IL-4 or IL-4 and IL-12 was not due
to increased susceptibility to S. mansoni infection per se.
|
During infection, liver-trapped parasite eggs elicit granulomatous
lesions. The size of these granulomas, which alter normal tissue
architecture, become fibrotic, and eventually lead to organ malfunctions, has been correlated with disease severity. To determine whether the morbidity observed in infected IL4/12
/
mice
was due to differences in granuloma size, we compared the diameters of
the lesions around trapped eggs in the different groups. Frontal liver
lobes were processed for histological examination of lesions, and
granulomas were imaged under a Nikon Optiphot microscope and captured
with a Sony 3CCD color video camera (Sony, Teaneck, N.J.). Granuloma
size was measured using NIH/SCION IMAGE (Scion, Frederick, Md.) (data
not shown) and an ocular micrometer (Table 1); remaining hepatic tissue
was used to assess egg burden. No significant differences in granuloma
diameter were recorded (ANOVA, P = 0.76) (Table 1).
Infected IL-4
/
mice mount an antigen (Ag)-specific
immune response deficient in type 2 cytokines and biased towards type 1 cytokine production (2, 5, 9, 15). To determine whether IL-12 contributes to the development of the type 1 response in infected
IL-4
/
mice, Ag-specific immune responses were measured
in infected IL-4/IL-12
/
animals. Single-cell
suspensions of splenocytes were prepared as previously described
(2). Cells used for cytokine assays were incubated either
alone, with 50 µg of soluble egg antigen (SEA) per ml
(1), or with 50 µg of SEA per ml plus 5 µg of lipopolysaccharide (LPS) per ml (2) (Sigma) in
96-well flat-bottom plates (Falcon, Lincoln Park, N.J.) at 37°C and
5% CO2. Cell culture supernatants were collected at
72 h and stored at
20°C until cytokine analysis was performed.
Reagents for enzyme-linked immunosorbent assays were either prepared as
previously described (IL-4 and IL-5) (21) or purchased
from Pharmingen, San Diego, Calif. (IFN-
and IL-10) or Genzyme,
Boston, Mass. (TNF-
). Differences in cytokine and NO levels between
groups were evaluated, using Student's t test. Levels of
cytokine production by WT and IL-12
/
mice were similar,
with the exception that infected IL-12
/
mice produced
significantly higher levels of IL-10 than did WT mice (Fig.
2). The levels of cytokines produced by
splenocytes from infected IL-4/IL-12
/
mice were,
in type and quantity, comparable to those produced by infected
IL-4
/
animals (Fig. 2). Specifically, there was a
significant decrease in type 2 cytokine (IL-5 and IL-10) levels and an
increase in IFN-
and TNF-
levels in response to Ag or Ag and LPS
in all IL-4-deficient mice (Fig. 2 and
3). The finding that IFN-
levels were
higher in the IL-4/IL-12
/
culture supernatants than in
the IL-4
/
samples was not consistently observed in all
experiments. Nitrite levels measured using the Griess reaction
(7) indicated that NO levels were higher in the culture
supernatants of Ag-stimulated splenocytes from infected
IL-4
/
and IL-4/IL-12
/
mice than from WT
and IL-12
/
samples (Fig.
4).
|
|
|
Based on these data, we conclude that the enhanced production of the
inflammatory mediators IFN-
, TNF-
, and NO and the development of
severe disease in schistosome-infected IL-4
/
mice are
IL-12 independent. Indeed, the absence of IL-12 had no discernable
effect on immune response or infection outcome. In the absence of IL-4,
a Th1-like response developed in an IL-12-independent manner, and in
the absence of IL-12 alone, the Th2 response was indistinguishable from
that in WT mice. The IL-12-independent development of IFN-
-producing
immune responses is uncommon but not unprecedented (8, 13,
18). Although the IL-12p40 homodimer may, in some circumstances,
act as an IL-12 agonist to stimulate IFN-
production
(17), splenocytes from IL-12p40
/
mice
produced levels of IFN-
comparable to those of WT and
IL-12p35
/
mice after anti-CD3 stimulation (data not
shown), indicating that in this setting, IL-12p40 did not act to
promote IFN-
production. Because disruption of the IL-12p35 gene did
not alter IFN-
production, it was not possible for us to directly
address the role of IFN-
in the development of severe disease that
occurs in the absence of IL-4. This issue will be addressed in the
future, using IL-4/IFN-
/
animals.
Due to the low number of IFN-
-producing cells in Ag-stimulated
cultures, we have not yet been able to definitively identify the
cellular source of Ag-stimulated IFN-
in mice lacking IL-4, although
schistosome-specific CD8 (14, 16) and CD4 (9) cells have been implicated in IFN-
production during infection. Further studies will be necessary to definitively identify the cellular
population which produces IFN-
following Ag-specific stimulation.
In this study, we have shown that the lack of IL-12 altered neither the course of schistosomiasis nor the accompanying immune response in WT mice. IL-12 was not necessary for the development of the proinflammatory condition seen in schistosome-infected IL-4-deficient mice.
| |
ACKNOWLEDGMENTS |
|---|
We thank Andrew MacDonald for critical review of the manuscript and the laboratory of Cornelia Farnum for technical advice and use of equipment.
This work was supported by National Institutes of Health grant AI32573 (to E.J.P.). E.A.P. is supported by National Research Service award (F32) AI10374; L.R.B. was supported by F32 AI09512 while at Cornell. A.C.L. is supported by F32 AI10151. The Basel Institute was founded by and is supported by Hoffman-La Roche. Schistosome life cycle stages for this work were supplied through NIH-NIAID contract N01-AI-55270.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology and Immunology, C5-165 VMC, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853. Phone: (607) 253-3389. Fax: (607) 253-3384. E-mail: ejp2{at}cornell.edu.
Present address: Division of Microbiology and Parasitology,
Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
Present address: Institute for Biological Sciences, National
Research Council, Ottawa, Ontario, Canada.
Editor: J. M. Mansfield
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Boros, D. L., and K. S. Warren. 1970. Delayed hypersensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs. J. Exp. Med. 132:488-507[Abstract]. |
| 2. |
Brunet, L. R.,
F. D. Finkelman,
A. W. Cheever,
M. A. Kopf, and E. J. Pearce.
1997.
IL-4 protects against TNF- mediated cachexia and death during acute schistosomiasis.
J. Immunol.
159:777-785[Abstract].
|
| 3. | Buck, M., and M. Chojkier. 1996. Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J. 15:1753-1765[Medline]. |
| 4. | Chiaramonte, M. G., D. D. Donaldson, A. W. Cheever, and T. A. Wynn. 1999. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J. Clin. Investig. 104:777-785[Medline]. |
| 5. |
Fallon, P. G.,
E. J. Richardson,
G. J. McKenzie, and A. N. McKenzie.
2000.
Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent.
J. Immunol.
164:2585-2591 |
| 6. | Garcia-Martinez, C., P. Costelli, F. J. Lopez-Soriano, and J. M. Argiles. 1997. Is TNF really involved in cachexia? Cancer Investig. 15:47-54[Medline]. |
| 7. | Green, L. C., D. A. Wagner, J. Glogowski, P. L. Skipper, J. S. Wishnok, and S. R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126:131-138[CrossRef][Medline]. |
| 8. |
Hoffmann, K. F.,
S. L. James,
A. W. Cheever, and T. A. Wynn.
1999.
Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni.
J. Immunol.
163:927-938 |
| 9. |
Jankovic, D.,
M. C. Kullberg,
N. Noben-Trauth,
P. Caspar,
J. M. Ward,
A. W. Cheever,
W. E. Paul, and A. Sher.
1999.
Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile.
J. Immunol.
163:337-342 |
| 10. | Kopf, M., G. Le Gros, M. Bachmann, M. C. Lamers, H. Bluethmann, and G. Kohler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362:245-248[CrossRef][Medline]. |
| 11. | Matthys, P., and A. Billiau. 1997. Cytokines and cachexia. Nutrition 13:763-770[CrossRef][Medline]. |
| 12. | Mattner, F., J. Magram, J. Ferrante, P. Launois, K. Di Padova, R. Behin, M. K. Gately, J. A. Louis, and G. Alber. 1996. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 26:1553-1559[Medline]. |
| 13. |
Oxenius, A.,
U. Karrer,
R. M. Zinkernagel, and H. Hengartner.
1999.
IL-12 is not required for induction of type 1 cytokine responses in viral infections.
J. Immunol.
162:965-973 |
| 14. | Pancre, V., M. Delacre, J. Herno, and C. Auriault. 1999. Schistosomal egg antigen-responsive CD8 T-cell population in Schistosoma mansoni-infected BALB/c mice. Immunology 98:525-534[CrossRef][Medline]. |
| 15. |
Pearce, E. J.,
A. Cheever,
S. Leonard,
M. Covalesky,
R. Fernandez-Botran,
G. Kohler, and M. Kopf.
1996.
Schistosoma mansoni in IL-4 deficient mice.
Int. Immunol.
8:435-444 |
| 16. | Pedras-Vasconcelos, J. A., and E. J. Pearce. 1996. Type 1 CD8+ T cell responses during infection with the helminth Schistosoma mansoni. J. Immunol. 157:3046-3053[Abstract]. |
| 17. | Piccotti, J. R., S. Y. Chan, K. Li, E. J. Eichwald, and D. K. Bishop. 1997. Differential effects of IL-12 receptor blockade with IL-12 p40 homodimer on the induction of CD4+ and CD8+ IFN-gamma-producing cells. J. Immunol. 158:643-648[Abstract]. |
| 18. |
Schijns, V. E.,
B. L. Haagmans,
C. M. Wierda,
B. Kruithof,
I. A. Heijnen,
G. Alber, and M. C. Horzinek.
1998.
Mice lacking IL-12 develop polarized Th1 cells during viral infection.
J. Immunol.
160:3958-3964 |
| 19. | Smithers, S. R., and R. J. Terry. 1965. The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology 55:695-700[Medline]. |
| 20. |
Tisdale, M. J.
1999.
Wasting in cancer.
J. Nutr.
129:243S-246S |
| 21. | Vella, A. T., M. D. Hulsebosch, and E. J. Pearce. 1992. Schistosoma mansoni eggs induce antigen-responsive CD44-hi T helper 2 cells and IL-4-secreting CD44-lo cells. Potential for T helper 2 subset differentiation is evident at the precursor level. J. Immunol. 149:1714-1722[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»